Literature DB >> 16437154

A case of therapy-related acute myeloid leukemia associated with inv(16), with subsequent development of t(9;22).

M Kim, J Lim, Y Kim, K Han, C-S Kang, H-J Kim, W-S Min.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16437154     DOI： 10.1038/sj.leu.2404058

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  Patterns of BCR breakpoints in patients with coexisting inv(16)(p13.1q22) and t(9;22)(q34;q11.2).

Authors:  Daniel Bustamante; Kathryn R Chan; David R Czuchlewski; A Amir Al Saadi
Journal:  Int J Hematol       Date:  2012-02-25       Impact factor: 2.490

2.  t(9;22) as secondary alteration in core-binding factor de novo acute myeloid leukemia.

Authors:  Candida Vitale; Xinyan Lu; Balkees Abderrahman; Koichi Takahashi; Farhad Ravandi; Elias Jabbour
Journal:  Am J Hematol       Date:  2015-10-12       Impact factor: 10.047

3.  Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities.

Authors:  Eunhee Han; Hyeyoung Lee; Myungshin Kim; Yonggoo Kim; Kyungja Han; Sung-Eun Lee; Hee-Je Kim; Dong-Wook Kim
Journal:  Blood Res       Date:  2014-03-24

Review 4.  Rare Cytogenetic Abnormalities and Alteration of microRNAs in Acute Myeloid Leukemia and Response to Therapy.

Authors:  Mohammad Shahjahani; Elahe Khodadi; Mohammad Seghatoleslami; Javad Mohammadi Asl; Neda Golchin; Zeynab Deris Zaieri; Najmaldin Saki
Journal:  Oncol Rev       Date:  2015-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.